AlphaCrest Capital Management’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-13,475
| Closed | -$384K | – | 1070 |
|
|
2022
Q3 | $384K | Buy |
13,475
+6,603
| +96% | +$188K | 0.02% | 1072 |
|
|
2022
Q2 | $311K | Buy |
+6,872
| New | +$311K | 0.02% | 1108 |
|
|
2022
Q1 | – | Sell |
-5,182
| Closed | -$772K | – | 1411 |
|
|
2021
Q4 | $772K | Sell |
5,182
-4,257
| -45% | -$634K | 0.03% | 917 |
|
|
2021
Q3 | $1.37M | Buy |
9,439
+7,326
| +347% | +$1.07M | 0.07% | 475 |
|
|
2021
Q2 | $414K | Buy |
+2,113
| New | +$414K | 0.02% | 1019 |
|
|
2021
Q1 | – | Sell |
-2,500
| Closed | -$354K | – | 1308 |
|
|
2020
Q4 | $354K | Buy |
+2,500
| New | +$354K | 0.03% | 840 |
|